FDA Inspection 1054003 — Nathan Segall, MD, CPI
The FDA completed an inspection of Nathan Segall, MD, CPI on April 26, 2018 in Stockbridge, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Tobacco.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 26, 2018
- Fiscal Year
- 2018
- Product Type
- Tobacco
- Project Area
- Bioresearch Monitoring
- Location
- Stockbridge, GA (United States)
Additional Details
Clinical Investigator (CI)